Nesbuvir

Known as: 5-Cyclopropyl-2-(4-fluorophenyl)-6-((2-hydroxyethyl)(methylsulfonyl)amino)-N-methyl-1-benzofuran-3-carboxamide 
A non-nuceoside polymerase inhibitor with activity against hepatitis C virus (HCV). Nesbuvir binds to the palm site II pocket of HCV NS5B polymerase… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2014-2017
012320142017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
This letter describes the discovery of a fused benzofuran scaffold viable for preparing a series of novel potent HCV NS5B… (More)
Is this relevant?
2017
2017
Allosteric inhibitors of hepatitis C virus (HCV) non-structural protein 5B (NS5B) polymerase are effective for treatment of… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2017
2017
With the introduction of direct-acting antivirals (DAAs), treatment against hepatitis C virus (HCV) has significantly improved… (More)
Is this relevant?
2017
2017
The development of direct-acting antivirals (DAAs) has significantly improved hepatitis C virus (HCV) treatment. However, drug… (More)
Is this relevant?
2014
2014
Direct-acting antivirals (DAAs) targeting proteins encoded by the hepatitis C virus (HCV) genome have great potential for the… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • table 2
Is this relevant?